October 24, 2022 All Stitched Up: A Decade Later, Nike Loses to Adidas on Obviousness By Abigail Ryckman
October 7, 2022 Moderna Tries to Send Message That It Owns the Commercial Rights to mRNA Technology in Suit Against Pfizer By Avi Strauss
October 6, 2022 Open-Source Software Users are Paying the Patent Troll Toll More Than Ever By Hannah Ashbrook
April 29, 2022 Where We Are Now on the COVID-19 TRIPS Proposal—Is an IP Waiver the Right Way to Address Vaccine Inequity? By Kelsey Price